Clariant, CH0012142631

Clariant stock downgraded by Barclays as chemical demand slows

Published on 11/17/2026 at 18:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Clariant stock was cut to Equal Weight by Barclays, which kept its CHF 11.50 target. The broker cited softer volumes and renewed litigation risk.

Barclays turns cautious on Clariant

  • Barclays cut its Clariant rating from Overweight to Equal Weight.
  • The bank kept its price target at CHF 11.50.
  • Clariant would need fourth-quarter EBITDA around 11% above its seasonally adjusted run-rate to reach the midpoint of its guidance, Barclays said.
Clariant, CH0012142631, Illustration mit AI erstellt.

Barclays downgraded Clariant from Overweight to Equal Weight on Monday, November 16, according to a Reuters report carried by Investing.com. The bank left its price target unchanged at CHF 11.50.

Demand concerns temper earnings outlook

Barclays said third-quarter earnings across European chemical makers were supported by higher prices rather than stronger demand. Volumes slowed amid weakness in agriculture, automotive and construction, limiting the scope for a more bullish view on Clariant.

The broker said Clariant's fourth-quarter EBITDA would need to run around 11% above its seasonally adjusted run-rate for the company to reach the midpoint of its guidance. Barclays also cited renewed litigation risk after Shell and Stichting Ethylene Claims appealed a July court dismissal, saying the shares showed limited evidence of that risk.

Company guidance remains the reference

Clariant reported third-quarter 2026 sales of CHF 968.8 million on November 3 and confirmed its full-year outlook, including an EBITDA margin before exceptional items of around 18%. The company said its order book for the final quarter was strong, particularly in Catalysts, while geopolitical conditions continued to weigh on that business.

Clariant describes itself as a specialty chemicals company with business units covering Care Chemicals, Catalysts and Adsorbents and Additives. Its medium-term targets include annual sales growth of 4% to 6% and an EBITDA margin of 19% to 21% by 2027 at the latest.

Clariant company facts

  • Company: Clariant
  • ISIN: CH0012142631
  • Sector: Specialty chemicals
  • Home market: Switzerland

The broader Swiss equity backdrop is covered in the SMI market environment.

More news and analyses on Clariant stock

Disclaimer...
en | CH0012142631 | CLARIANT | boerse | 70528209 | bgmi